Ralph-Williams Rebecca J, Lehmann-Masten Virginia, Otero-Corchon Veronica, Low Malcolm J, Geyer Mark A
Alcohol and Drug Abuse Research Center, Harvard Medical School and McLean Hospital, Belmont, Massachusetts 02478, USA.
J Neurosci. 2002 Nov 1;22(21):9604-11. doi: 10.1523/JNEUROSCI.22-21-09604.2002.
Stimulation of the dopamine (DA) system disrupts prepulse inhibition (PPI) of the acoustic startle response. On the basis of rat studies, it appeared that DA D2 receptors (D2Rs) rather than D1 receptors (D1Rs) regulate PPI, albeit possibly in synergism with D1Rs. To characterize the DA receptor modulation of PPI in another species, we tested DA D1R and D2R mutant mice with direct and indirect DA agonists and with the glutamate receptor antagonist, dizocilpine (MK-801). Neither the mixed D1/D2 agonist apomorphine (5 mg/kg) nor the more selective D1-like agonist SKF82958 (0.3 mg/kg) altered PPI in D1R knock-out mice, although both compounds disrupted PPI in D2R mutant and wild-type mice, suggesting that the D1R alone might modulate PPI in mice. However, amphetamine (10 mg/kg) significantly lowered PPI in each genotype of D1R mice, suggesting that the D1R is not necessary for the PPI-disruptive effect of the indirect agonist in mice. As reported previously, amphetamine (10 mg/kg) failed to disrupt PPI in D2R knock-out mice, supporting a unique role of the D2R in the modulation of PPI. Dizocilpine (0.3 mg/kg) induced similar PPI deficits in D1R and D2R mutant mice, confirming that the influences of the NMDA receptor on PPI are independent of D1Rs and D2Rs in rodents. Thus, both D1Rs and D2Rs modulate aspects of PPI in mice in a manner that differs from dopaminergic modulation in rats. These findings emphasize that further cross-species comparisons of the pharmacology of PPI are essential to understand the relevance of rodent PPI studies to the deficits in PPI observed in patients with schizophrenia.
多巴胺(DA)系统的刺激会破坏听觉惊吓反应的前脉冲抑制(PPI)。基于大鼠研究,似乎是DA D2受体(D2Rs)而非D1受体(D1Rs)调节PPI,尽管可能与D1Rs协同作用。为了在另一个物种中表征DA受体对PPI的调节作用,我们用直接和间接DA激动剂以及谷氨酸受体拮抗剂地佐环平(MK-801)对DA D1R和D2R突变小鼠进行了测试。混合的D1/D2激动剂阿扑吗啡(5 mg/kg)和更具选择性的D1样激动剂SKF82958(0.3 mg/kg)均未改变D1R基因敲除小鼠的PPI,尽管这两种化合物均破坏了D2R突变小鼠和野生型小鼠的PPI,这表明单独的D1R可能调节小鼠的PPI。然而,苯丙胺(10 mg/kg)显著降低了每种基因型D1R小鼠的PPI,这表明D1R对于间接激动剂在小鼠中破坏PPI的作用并非必需。如先前报道,苯丙胺(10 mg/kg)未能破坏D2R基因敲除小鼠的PPI,支持了D2R在调节PPI中的独特作用。地佐环平(0.3 mg/kg)在D1R和D2R突变小鼠中诱导了相似的PPI缺陷,证实了NMDA受体对PPI的影响在啮齿动物中独立于D1Rs和D2Rs。因此,D1Rs和D2Rs均以不同于大鼠多巴胺能调节的方式调节小鼠PPI的各个方面。这些发现强调,对PPI药理学进行进一步的跨物种比较对于理解啮齿动物PPI研究与精神分裂症患者中观察到的PPI缺陷的相关性至关重要。